Pfizer has low forward P/E ratios for the next five years. The FY2027 forward P/E ratio is low at 8.61. On the other hand, we see that the ratio will not shrink significantly between FY2024 and FY2027 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback